Presentations from the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

Contents:

SESSION I. PATIENT POPULATION PRIOR TO DIAGNOSIS OF PROSTATE CANCER:
SCREENING AND CLINICAL EVALUATION OF MEN WITH CLINICAL SUSPICION

Welcome and Opening Remarks

Faina Shtern, MD, presented opening remarks for Fifth Global Summit on Precision Diagnosis and Treatment of Prostate Cancer.

.

Risk-Stratified Screening and Early Detection of Prostate Cancer in 2021

Sigrid Carlsson, MD, PhD, MPH, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

Clinical Perspective on Current and Emerging Liquid Diagnostics

E. David Crawford, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

4Kscore Test

Peter Scardino, MD, FACS, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

The Sentinel Prostate Cancer Platform: Validation Studies

Laurence Klotz, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

Prostate Biopsy: The Re-Emergence of Transperineal Prostate Biopsy

Edward Schaeffer, MD, PhD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

Radiologic Perspective on the Clinical Utility of and Emerging Data on Micro-Ultrasound

Sangeet Ghai, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

Urologic Perspective on the Clinical Utility of & Emerging Data on Micro-Ultrasound & the Upcoming OPTIMUM Trial

Rafael Sanchez-Salas, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

Contrast-Enhancd Ultrasound of the Prostate

Ethan Halpern, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

Recent Advancements in PI-RADS: mpMRI vs. bpMRI

Jelle Barentsz, MD, PhD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

American College of Radiology: Prostate MRI Quality Initiatives

Jeffrey Weinreb, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

Prostate Imaging Elevated By Deep Learning

Mukesh Harisinghani, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

MRI-Targeted Biopsy of the Prostate: Optimizing Patient Selection and Technique

Fergus Coakley, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

Transperineal Biopsy & Classification of Risk Using Novel Gleason Pattern Quantification

Behfar Ehdaie, MD, MPH, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

Integrated Multi-Modality Diagnostic Evaluation in Prostate Cancer

Robert E. Reiter, MD, MBA, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

Updates of Changes in the Early Detection of Prostate Cancer NCCN Guidelines 2021

Preston C. Sprenkle, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

SESSION II. CLINICAL EVALUATION AND MANAGEMENT OF MEN WITH LOCALIZED AND RECURRENT PROSTATE CANCER

Germline Genetics, Urine, and Prostate Cancer Aggressivity

Paul C. Boutros, PhD, MBA, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

Prostate Cancer: Tissue-Based Genetic Cancer Profiling

Alan Pollack, MD, PhD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

Use of MRI-Targeting Increases Overdiagnosis and Overtreatment

Andrew Vickers, PhD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

Prostate: Anatomic Considerations

Thomas Wheeler, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

Overview of Prostate Imaging and mpMRI

Clare Tempany, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

Experience with 18F-rhPSMA7.3

Wolfgang Weber, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.
.

Doctor Knows Best? Why Prostate Cancer Care Must Be Transformed Into Digital Health

Michael Johnson, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 23, 2021.

Emerging Role of PSMA Imaging

Steven P. Rowe, MD, PhD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

PSMA PET-CT: Clinical Applications

Neal D. Shore, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Clinical Utility of 18F-Fluciclovine (FACBC, Axumin) PET Scans

Gerald L. Andriole, Jr., MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Neuroendocrine Tumor Imaging and Radionuclide Treatment

Thomas Hope, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Urologic Perspective on the Current and Emerging Role of Multi-Modality Imaging and Radiogenomics

Mohummad Minhaj Siddiqui, MD, FACS, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Integrated Diagnostics and Patient Selection for Active Surveillance vs. Immediate Treatment

Sanoj Punnen, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Selection and Monitoring of Image-Targeted Minimally Invasive Prostate Cancer Treatment

Fiona Fennessy, MD, PhD, FACR, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Role of Imaging for Precision Radiation Treatment

Ashesh B. Jani, MD, MSEE, FASTRO, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Surgical Treatment for Prostate Cancer in the Modern Era

Adam S. Feldman, MD, MPH, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

NCCN Guidelines for Treatment of Localized Prostate Cancer

Kelvin A. Moses, MD, PhD, FACS, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

SESSION III. POPULATION OF MEN WITH ADVANCED PROSTATE CANCER

Standard Treatments and Global Perspective

Marc B. Garnick, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Precision Oncology in Prostate Cancer

Daniel P. Petrylak, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Epigenetic Modulations in Advanced Prostate Cancer

Himisha Beltran, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Novel Treatment and its Integration with Precision Diagnostics

David M. Nanus, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Molecular and Multi-Modality Imaging and Theranostics: Overview

Wolfgang Weber, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Practical Applications and Clinical Utility of the FDA-Approved PSMA PET Imaging Agent: Implications for Urology and Radiation Oncology

Phillip J. Koo, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

Defining Non-Metastatic vs. Oligometastatic vs. Systemic Disease

Jeremie Calais, MD, MSc, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

PSMA: Current State of the Art and Future Vision

Phillip J. Koo, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 24, 2021.

SESSION IV. PRECISION DIAGNOSTICS AND EMERGING ROLE OF IMAGE-TARGETED, MINIMALLY INVASIVE TREATMENT: Multimodality Diagnostics for Improved Target Definition, Patient Selection, Monitoring & Outcomes

Practical Precision Diagnostics and Emerging Role of Image Targeted Minimally Invasive Treatment

Jurgen Fütterer, MD, PhD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Current and Emerging Role of Radiogenomics

John F. Feller, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

MRI Guided Focal Laser Ablation

Aytekin Oto, MD, MBA, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Follow-up of Focal Cryoablation and Novel Pulse Sequences to Characterize the Treatment Zone

Daniel Margolis, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

MRI Guided Partial and Whole Prostate Gland Treatment

Steven S. Raman, MD, FSAR, FSIR, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Transurethral Ultrasound Ablation (TULSA)

Robert Princenthal, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Urologic Perspective on Clinical Utility and Outcomes of Focal Therapy

Jim C. Hu, MD, MPH, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Focal Treatment of Prostate Cancer: The Case for Radiotherapy

Daniel Song, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Image-Guided Focal Treatment of Prostate Cancer

Scott Eggener, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

PANEL ON PRECISION CARE AND HEALTH DISPARITIES IN PROSTATE CANCER

Racial Differences in Prostate Cancer Outcomes

Quoc-Dien Trinh, MD, FACS, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Genetic and Prostate Cancer Disparities Facing African Americans

Adam B. Murphy, MD, MBA, MSCI, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

PANEL ON BIOINFORMATICS, ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING FOR A MULTI-MODALITY DATA ANALYSIS FOR PRECISION DIAGNOSIS AND TREATMENT

Personalization of Prostate Cancer Care Through Integration of Data

Ilya Gipp, MD, PhD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Clinical Perspective on the Emerging and Potential Role of Machine Learning

Masoom Haider, MD, FRCP (C), presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Artificial Intelligence, Radiomics, Pathomics: Diagnosis, Prognosis and Treatment Response for Prostate Cancer

Anant Madabhushi, PhD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Artificial Intelligence to Prostate Cancer in MRI

Liang Wang, MD, PhD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Update on Multi Factorial Nomograms

Amita Shukla-Dave, PhD and Andreas G. Wibmer, MD, presented this lecture during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 25, 2021.

Abstract Competition Winners

First Place
Abstract #1 – University of Chicago School of Medicine (Multi-Institutional Clinical Trial)

Safety and Feasibility of Intraprostatic Injection of CAN-2409 or Placebo followed by Valacyclovir in Patients on Active Surveillance for Prostate Cancer (ULYSSES Trial)

Submitted by: Scott Eggener, MD, University of Chicago School of Medicine

Second Place (Tied)
Abstract #7 – Washington University School of Medicine in St. Louis, Leeds Teaching Hospitals NHS Trust and Blue Earth Diagnostics

Impact of 18F-Fluciclovine PET/CT on Plans for ADT in Patients with Biochemical Recurrence of Prostate Cancer; Analysis from Two Prospective Clinical Trials

Submitted by: Gerald Andriole, MD, Washington University School of Medicine

Third Place
Abstract #7 – Abstract #16 – Lantheus Medical Imaging

OSPREY and CONDOR: Results from Two Registrational Clinical Studies Assessing the Diagnostic Performance of Piflufolastat F 18 (PYLARIFY®) PET/CT in Patients with High-Risk and Recurrent Prostate Cancer

Submitted by: Bela Denes, MD